Revenge, no need to personalize the Sunrise failure. Given what King and company knew and had reason to expect, I think they were making good decisions. Reality by way of the clinic intruded on what looked like a promising plan. Sh*t happens.
The only important question now is how does Peregrine proceed. I would like to see management recognition of how serious the situation has become. I would like to see them act accordingly. By which I mean slash the burn rate as close to zero as possible, preferably use Avid to turn a profit.
Bavi-immunotherapy combo trials may be worth pursuing, but only if they can find more money from Avid or a partner. Management has some responsibility to the shareholders who have supported their efforts. The owe us better than another round of ATM selling at these depressed levels.
GLTA, Paul
News 
Market Data 
Discover 
